Tanzania Biomaterials in Healthcare Market Report 2022 to 2030

Tanzania Biomaterials in Healthcare Market Analysis

$ 3999

The Tanzania Biomaterials in Healthcare Market is expected to witness growth from $63 Mn in 2022 to $180 Mn in 2030 with a CAGR of 14.10% for the forecasted year 2022-2030. Tanzania's Biomaterials in Healthcare market is expanding quickly due to the country's expanding population and rising desire for healthcare services. The market is segmented by type and by application. Some key players in this market include: Zenufa Laboratories, Crown Healthcare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10TZMD003 CATEGORY: Medical Devices GEOGRAPHY: Tanzania AUTHOR: Jigyasu Bhandari

Buy Now

Tanzania Biomaterials in Healthcare Market Executive Analysis

The Tanzania Biomaterials in Healthcare Market size is at around $63 Mn in 2022 and is projected to reach $180 Mn in 2030, exhibiting a CAGR of 14.10% during the forecast period. In Tanzania, the average person's healthcare expenses were $41 in 2021. The United Republic of Tanzania saw a rise in health spending per person from $20 in 2015 to $40 in 2019, growing at an average annual rate of 6.91%. Tanzania's health industry will receive $0.94 billion in nominal funding in 2020, a 0.4% decrease from the $0.93 billion allocated in 2018. From 7.0% and 1.80%, respectively, the allotment has dropped to 6.7% of the total national budget and 1.5% of GDP.

In Tanzania, Biomaterials are substances that are used to replace or repair injured human bodily tissues in tissue engineering, implants, and medical equipment. They are a rapidly developing area with a wide range of applications in Tanzanian healthcare. Biomaterials are used to create implants that replace missing or damaged bodily parts, such as pacemakers, dental implants, and hip or knee joints. Biomaterials can be used to create scaffolds or matrices that encourage the development of new tissues, like bone or cartilage, in people with injuries or degenerative diseases. Biomaterials can be used to create drug delivery systems that transport medication at a controlled rate and target specific body parts for treatment. Biomaterials can be used to create dressings and other wound care supplies to speed up recovery and prevent infection. Biomaterials are designed to be inert with human tissues, which reduces the risk of rejection and hastens healing. Biomaterials are designed to last a very long period and are therefore replaced less often. Because they can be customized to meet the specific requirements of each patient, biomaterials offer individualized treatment options. Biomaterials can shorten the duration of the rehabilitation process by promoting faster healing and reducing the likelihood of complications. Biomaterials can enhance human life by providing treatments for illnesses that were previously incurable.

tanzania biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

Tanzania's Biomaterials in Healthcare market is expanding quickly due to the country's expanding population and rising desire for healthcare services. In order to support the operations of healthcare, there is an increasing demand for biomaterials. Progressive diseases like heart disease have become more prevalent in Tanzania. The market for manufacturers is expanding as a result of these conditions frequently requiring medical devices and biomaterials to support governance and treatment. The government of Tanzania has been spending money on healthcare facilities and services, including building new hospitals and clinics. The opportunity to offer medical equipment and materials to support these facilities has been made possible by this investment for producers of biomaterials.

Market Restraints

Tanzania suffers from a lack of qualified healthcare professionals, which may hinder the adoption of innovative biomaterials. Healthcare professionals may be reluctant to embrace new tools or materials if they have not been trained in their use, even if those tools or materials have the potential to be beneficial. Most Tanzanians lack access to health insurance, which may restrict their capacity to pay for medical services and biomaterials.

Competitive Landscape

Key Players

Zenufa Laboratories (TZA)
Crown Healthcare (TZA)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Healthcare Policies and Regulatory Landscape

Tanzania's Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) and Tanzania Food and Drug Authority are in charge of the country's healthcare laws and regulations. (TFDA). The Tanzania Food and Drug Authority (TFDA) is in charge of Tanzania's biomaterials regulation framework. Medical equipment, pharmaceutical, and other healthcare product importation, production, distribution, and sales are subject to TFDA regulation. Companies must acquire regulatory approval from the TFDA in order to sell biomaterials in Tanzania. Regulations for biomaterials have been put in place by the TFDA, which include standards for labelling, licensing, and quality assurance. A Medical Devices Assessment Committee (MDAC) has also been created by the TFDA to examine and assess requests for regulatory approval of medical devices, including biomaterials. Before approving a medical gadget for use, the MDAC assesses its quality, safety, and efficacy.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Tanzania market in 2019. The growing geriatric population Tanzanialy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.